Apple Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 23-10-2024
- Paid Up Capital ₹ 22.64 K
as on 23-10-2024
- Company Age 18 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 9.56 Cr
as on 23-10-2024
- Revenue -98.88%
(FY 2023)
- Profit -98.62%
(FY 2023)
- Ebitda -98.43%
(FY 2023)
- Net Worth -98.71%
(FY 2023)
- Total Assets -98.88%
(FY 2023)
About Apple Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 22.64 K .
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹9.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naveen Khaitan, Rahul Khaitan, Binod Jha, and One other member serve as directors at the Company.
- CIN/LLPIN
U24121DL2006PTC148648
- Company No.
148648
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Apple Formulations Private Limited. offer?
Apple Formulations Private Limited. offers a wide range of products and services, including Allopathic Cough Syrup, Benadryl Cough Syrup.
Who are the key members and board of directors at Apple Formulations?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Khaitan  | Director | 06-May-2006 | Current |
| Rahul Khaitan | Director | 03-Jul-2006 | Current |
| Binod Jha | Director | 09-Jan-2019 | Current |
| Ram Dwivedi | Director | 08-May-2023 | Current |
Financial Performance of Apple Formulations.
Apple Formulations Private Limited., for the financial year ended 2023, experienced significant reduction in revenue, with a 98.88% decrease. The company also saw a substantial fall in profitability, with a 98.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 98.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apple Formulations?
In 2022, Apple Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Franklin Healthcare Private LimitedActive 13 years 7 months
Naveen Khaitan and Rahul Khaitan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Aug 2018 | ₹15.00 Cr | Open |
Others Creation Date: 18 Jul 2020 | ₹2.30 M | Satisfied |
Others Creation Date: 09 Jun 2018 | ₹5.28 Cr | Satisfied |
How Many Employees Work at Apple Formulations?
Apple Formulations has a workforce of 81 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apple Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apple Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
